Wu; Jim Zhen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wu; Jim Zhen.The latest application filed is for "compounds for the treatment and prophylaxis of respiratory syncytial virus disease".

Company Profile

1.12.12

Wu; Jim Zhen - Shanghai CN
Wu; Jim Zhen - Aliso Viejo CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-di- methylbutanamide as potassium channel modulators Grant 8,993,593 - Vernier , et al. March 31, 2	2015-03-31
Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease Grant 8,871,756 - Chen , et al. October 28, 2	2014-10-28
3,3-dimethyl tetrahydroquinoline derivatives Grant 8,586,747 - Chen , et al. November 19, 2	2013-11-19
Compounds For The Treatment And Prophylaxis Of Respiratory Syncytial Virus Disease App 20130196974 - Chen; Li ; et al.	2013-08-01
Benzyloxy anilide derivatives useful as potassium channel modulators Grant 8,492,588 - Wu , et al. July 23, 2	2013-07-23
Novel 3,3-dimethyl Tetrahydroquinoline Derivatives App 20130023518 - Chen; Li ; et al.	2013-01-24
3,3-dimethyl tetrahydroquinoline derivatives Grant 8,344,137 - Chen , et al. January 1, 2	2013-01-01
Benzyloxy Anilide Derivatives Useful As Potassium Channel Modulators App 20120329869 - Wu; Jim Zhen ; et al.	2012-12-27
Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators Grant 8,293,911 - Vernier , et al. October 23, 2	2012-10-23
Benzyloxy anilide derivatives useful as potassium channel modulators Grant 8,188,314 - Wu , et al. May 29, 2	2012-05-29
3-hydroxyisothiazole-4-carboxamidine derivatives as CHK2 inhibitors Grant 8,067,452 - Wu , et al. November 29, 2	2011-11-29
Novel 3,3-dimethyl Tetrahydroquinoline Derivatives App 20110257151 - Chen; Li ; et al.	2011-10-20
1,4 diamino bicyclic retigabine analogues as potassium channel modulators Grant 8,030,518 - Chen , et al. October 4, 2	2011-10-04
Compounds For The Treatment And Prevention Of Influenza App 20110195979 - Chen; Li ; et al.	2011-08-11
Derivatives Of 4-(n-azacycloalkyl) Anilides As Potassium Channel Modulators App 20110003850 - Vernier; Jean-Michel ; et al.	2011-01-06
Benzyloxy Anilide Derivatives Useful As Potassium Channel Modulators App 20090326059 - Wu; Jim Zhen ; et al.	2009-12-31
3-hydroxyisothiazole-4-carboxamidine Derivatives As Chk2 Inhibitors App 20090137041 - Wu; Jim Zhen ; et al.	2009-05-28
1,4 Diamino Bicyclic Retigabine Analogues As Potassium Channel Modulators App 20080234334 - CHEN; Huanming ; et al.	2008-09-25
Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators App 20080139610 - Vernier; Jean-Michel ; et al.	2008-06-12
Di-ribonucleotides as specific viral RNA-polymerase inhibitors for the treatment or prevention of viral infections App 20040158054 - Wu, Jim Zhen ; et al.	2004-08-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.